Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Avanafil

    Client Email Product

    Avanafil

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    22
    US DMFs Filed

    US DMFs Filed

    6
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    2
    Other Suppliers

    Other Suppliers

    15
    API REF. PRICE (USD / KG)
    2,208

    API Market Place

    6
    INTERMEDIATES
    4
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    3
    Europe

    Europe

    5
    Canada

    Canada

    0

    Australia

    Australia

    3
    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    4
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    48
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    3

    USFDA Exclusivities

    3
    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    23
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    27
    SERVICES

    0

    left grey arrow
    right gray arrow
    • TABLET;ORAL - 100MG
    • TABLET;ORAL - 200MG
    • TABLET;ORAL - 50MG
    Full View ScreenFull Screen View
    Petros Pharma's STENDRA Tablets Reported Improvement in Erectile Function
    Petros Pharma's STENDRA Tablets Reported Improvement in Erectile Function

    https://feeds.issuerdirect.com/news-release.html?newsid=6687692575178929

    PRESS RELEASE
    08 Sep 2022
    Share Share
    Petros Pharma Announces Positive Results of OTC Label Comprehension Study
    Petros Pharma Announces Positive Results of OTC Label Comprehension Study

    https://www.globenewswire.com/news-release/2022/04/19/2424598/0/en/Petros-Pharmaceuticals-Announces-Positive-Results-of-Over-the-Counter-OTC-Label-Comprehension-Study-for-Erectile-Dysfunction-Drug-STENDRA-avanafil.html

    GLOBENEWSWIRE
    19 Apr 2022
    Share Share
    Petros Partners with Global Contract Manufacturer for STENDRA's production
    Petros Partners with Global Contract Manufacturer for STENDRA's production

    https://www.prnewswire.com/news-releases/petros-pharmaceuticals-partners-with-leading-global-contract-manufacturer-to-bring-production-of-erectile-dysfunction-drug-stendrao-avanafil-to-the-united-states-301466260.html

    PRNEWSWIRE
    24 Jan 2022
    Share Share
    Petros Pharma Launches Two Self-Selection Studies for STENDRA
    Petros Pharma Launches Two Self-Selection Studies for STENDRA

    https://www.prnewswire.com/news-releases/petros-pharmaceuticals-launches-two-self-selection-studies-for-erectile-dysfunction-drug-stendra-avanafil-301461819.html

    PRNEWSWIRE
    18 Jan 2022
    Share Share
    Petros Pharmaceuticals Reports Q3 Financial Results, Provides Corporate Update
    Petros Pharmaceuticals Reports Q3 Financial Results, Provides Corporate Update

    https://www.prnewswire.com/news-releases/petros-pharmaceuticals-reports-third-quarter-financial-results-and-provides-corporate-update-301424600.html

    PRNEWSWIRE
    15 Nov 2021
    Share Share
    Petros Partners with Hims & Hers Health Generates 476% Growth of STENDRA Sales
    Petros Partners with Hims & Hers Health Generates 476% Growth of STENDRA Sales

    https://www.prnewswire.com/news-releases/petros-pharmaceuticals-inc-through-exclusive-marketing-agreement-with-hims--hers-health-inc-generates-476-year-over-year-growth-of-stendra-tablet-sales-301415346.html

    PRNEWSWIRE
    03 Nov 2021
    Share Share
    Petros Completes Pilot Label Comprehension Study to Start Process for Stendra®
    Petros Completes Pilot Label Comprehension Study to Start Process for Stendra®

    https://www.prnewswire.com/news-releases/petros-pharmaceuticals-completes-pilot-label-comprehension-study-to-initiate-process-for-stendra-prescription-erectile-dysfunction-medication-to-achieve-designation-as-an-over-the-counter-treatment-301332638.html

    PRNEWSWIRE
    13 Jul 2021
    Share Share
    Petros Establishes Steering Committee to Expand into Non-Rx Status for Stendra®
    Petros Establishes Steering Committee to Expand into Non-Rx Status for Stendra®

    https://www.prnewswire.com/news-releases/petros-pharmaceuticals-establishes-steering-committee-to-expand-into-non-rx-status-for-stendra-avanafil-301222109.html

    PRNNEWSWIRE
    04 Feb 2021
    Share Share
    Obliterated by Alzheimer's failure, Neurotrope relinquishes reverse merger
    Obliterated by Alzheimer's failure, Neurotrope relinquishes reverse merger

    https://endpts.com/obliterated-by-alzheimers-failure-neurotrope-relinquishes-its-nasdaq-spot-in-reverse-merger/

    Natalie Grover ENDPTS
    18 May 2020
    Share Share
    Neurotrope & Metuchen Pharmac Announce Merger Agreement to Form Petros
    Neurotrope & Metuchen Pharmac Announce Merger Agreement to Form Petros

    https://www.prnewswire.com/news-releases/neurotrope-and-metuchen-pharmaceuticals-announce-merger-agreement-to-form-petros-pharmaceuticals-a-mens-health-company-301060769.html

    PRNEWSWIRE
    18 May 2020
    Share Share
    Acerus Receives Notice of Deficiency From Health Canada Regarding Avanafil
    Acerus Receives Notice of Deficiency From Health Canada Regarding Avanafil

    https://www.businesswire.com/news/home/20200420005202/en/Acerus-Receives-Notice-Deficiency-Health-Canada-Avanafil

    BUSINESSWIRE
    20 Apr 2020
    Share Share
    Metuchen Pharmaceuticals, LLC. receives FDA Warning Letter
    Metuchen Pharmaceuticals, LLC. receives FDA Warning Letter

    https://www.pharmacompass.com/pdf/news/metuchen-pharmaceuticals-llc-receives-fda-warning-letter-1568282306.pdf

    FDA
    03 Sep 2019
    Share Share
    FDA's OPDP Warns Metuchen Pharmaceuticals Over Misleading DTC Ads
    FDA's OPDP Warns Metuchen Pharmaceuticals Over Misleading DTC Ads

    https://www.raps.org/news-and-articles/news-articles/2019/8/fdas-opdp-warns-metuchen-pharmaceuticals-over-mis

    Zachary Brennan RAPS
    27 Aug 2019
    Share Share
    STENDRA (avanafil): Metuchen Pharma, Mitsubishi Tanabe Pharma vs. Empower Pharma
    STENDRA (avanafil): Metuchen Pharma, Mitsubishi Tanabe Pharma vs. Empower Pharma

    https://insight.rpxcorp.com/litigation_documents/13143778

    PATENT LITIGATION
    24 Nov 2018
    Share Share
    STENDRA® (avanafil): Metuchen Pharmaceuticals LLC v. Empower Pharmaceuticals LLC et al
    STENDRA® (avanafil): Metuchen Pharmaceuticals LLC v. Empower Pharmaceuticals LLC et al

    https://www.pharmacompass.com/pdf/news/stendra-avanafil-metuchen-pharmaceuticals-llc-v-empower-pharmaceuticals-llc-et-al-1531147426.pdf

    PATENT LITIGATION
    09 Jul 2018
    Share Share
    Sanofi, following in Endo's footsteps, back rights to Vivus on ED med Stendra
    Sanofi, following in Endo's footsteps, back rights to Vivus on ED med Stendra

    http://www.fiercepharma.com/marketing/sanofi-following-endo-s-footsteps-hands-back-rights-to-vivus-ed-med-stendra

    Carly Helfand FIERCE PHARMA
    29 Mar 2017
    Share Share
    Sanofi gives up certain regional rights to Stendra
    Sanofi gives up certain regional rights to Stendra

    https://www.thepharmaletter.com/article/sanofi-gives-up-certain-regional-rights-to-stendra

    THE PHARMALETTER
    28 Mar 2017
    Share Share
    Post-Endo pact, will Vivus go it alone on U.S. Stendra marketing--and should it?
    Post-Endo pact, will Vivus go it alone on U.S. Stendra marketing--and should it?

    http://www.fiercepharma.com/marketing/post-endo-pact-will-vivus-go-it-alone-u-s-stendra-marketing-and-should-it

    Carly Helfand FIERCE PHARMA
    05 Aug 2016
    Share Share
    Menarini AP to market Mitsubishi Tanabe's Spedra in 10 Asia-Pacific countries
    Menarini AP to market Mitsubishi Tanabe's Spedra in 10 Asia-Pacific countries

    http://www.pharmabiz.com/NewsDetails.aspx?aid=93775&sid=2

    PHARMABIZ
    29 Feb 2016
    Share Share
    Pharma ad budgets stay flat, even as spending jumps across the board
    Pharma ad budgets stay flat, even as spending jumps across the board

    http://www.fiercepharmamarketing.com/story/pharma-ad-budgets-stay-flat-even-spending-jumps-across-board-report/2015-12-09

    Emily Wasserman FIERCE PHARMA MARKETING
    09 Dec 2015
    Share Share
    Endo plots a relaunch of Auxilium's ED med, complete with new salesforce and DTC
    Endo plots a relaunch of Auxilium's ED med, complete with new salesforce and DTC

    http://www.fiercepharmamarketing.com/story/endo-plots-relaunch-auxiliums-ed-med-complete-new-salesforce-and-dtc/2015-05-12

     Carly Helfand FIERCE PHARMA MARKETING
    13 May 2015
    Share Share
    FDA Provides Generic Approval Roadmap for 38 Drugs, Including Vertex's Kaldeco
    FDA Provides Generic Approval Roadmap for 38 Drugs, Including Vertex's Kaldeco

    http://www.raps.org/Regulatory-Focus/News/2015/03/09/21677/FDA-Provides-Generic-Approval-Roadmap-for-38-Drugs-Including-Vertexs-Kaldeco/

    Alexander Gaffney RAPS
    11 Mar 2015
    Share Share
    Endo ends Stendra marketing pact, leaving Vivus in the lurch
    Endo ends Stendra marketing pact, leaving Vivus in the lurch

    http://www.fiercepharmamarketing.com/story/endo-ends-stendra-marketing-pact-leaving-vivus-lurch/2016-01-03

    Carly Helfand FIERCE PHARMA MARKETING
    05 Jan 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search